Michael Thomas Henderson, Chief Business Officer at BridgeBio Pharma, Inc. (BBIO), sold 16,353 shares at $45.00 ($732K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Open-market sale of $732k BBIO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.33 | 6,353 | $282K | 38.5% |
| 2 | $45.00 | 10,000 | $450K | 61.5% |
| Total | $44.74 avg | 16,353 | $732K | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |